Cite
HARVARD Citation
Li, R. et al. (2022). Immunosuppressant and neuromyelitis optica spectrum disorder: optimal treatment duration and risk of discontinuation. European journal of neurology. pp. 2792-2800. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Li, R. et al. (2022). Immunosuppressant and neuromyelitis optica spectrum disorder: optimal treatment duration and risk of discontinuation. European journal of neurology. pp. 2792-2800. [Online].